Role of androgens in normal and pathological ovarian function

Reproduction

Volumn 149, Issue 4, 2015, Pages R193-R218

  Walters, K A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; CYTOCHROME P450; DIHYDROTACHYSTEROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; GONADOTROPIN; HEAT SHOCK PROTEIN; HYDROXYSTEROID DEHYDROGENASE; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; SOMATOMEDIN C; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ADRENAL GLAND; ANDROGEN METABOLISM; ANDROGEN RELEASE; ANDROGEN SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL SPECIFICITY; COMPLEX FORMATION; CONTROLLED STUDY; CORPUS LUTEUM; CUMULUS CELL; DNA BINDING; EMBRYO DEVELOPMENT; FEMALE; FEMALE FERTILITY; FOLLICULAR PHASE; GENE DOSAGE; GENE TARGETING; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GONADOTROPIN BLOOD LEVEL; GRANULOSA CELL; HORMONE RELEASE; HUMAN; LIGAND BINDING; META ANALYSIS (TOPIC); MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; OOCYTE MATURATION; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; THECA CELL; ANIMAL; CYTOLOGY; DRUG EFFECTS; MALE; METABOLISM; OVARIAN DISEASES; OVARY; PATHOLOGY;

ANIMALIA;

ANDROGENS; ANIMALS; FEMALE; HUMANS; MALE; MICE; OVARIAN DISEASES; OVARY; RECEPTORS, ANDROGEN;

EID: 84929155317     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-14-0517     Document Type: Review

References (232)

1. Abbott DH & Hearn JP 1978 The effects of neonatal exposure to testosterone on the development of behaviour in female marmoset monkeys. Ciba Foundation Symposium 14-16 299-327.
2. Abbott DH, Barnett DK, Bruns CM & Dumesic DA 2005 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Human Reproduction Update 11 357-374. (doi:10.1093/humupd/dmi013)
3. Abbott DH, Tarantal AF & Dumesic DA 2009 Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. American Journal of Primatology 71 776-784. (doi:10.1002/ajp.20679)
4. Abbott DH, Nicol LE, Levine JE, Xu N, Goodarzi MO & Dumesic DA 2013 Nonhuman primate models of polycystic ovary syndrome. Molecular and Cellular Endocrinology 373 21-28. (doi:10.1016/j.mce.2013.01.013)
5. Abi SB, Herkimer C, Lee JS, Veiga-Lopez A & Padmanabhan V 2012 Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology 153 2813-2822. (doi:10.1210/en.2011-2074)
6. Abraham GE 1974 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 39 340-346. (doi:10.1210/jcem-39-2-340)
7. Almahbobi G, Nagodavithane A & Trounson AO 1995 Effects of epidermal growth factor, transforming growth factor a and androstenedione on follicular growth and aromatization in culture. Human Reproduction 10 2767-2772.
8. Anderiesz C & Trounson AO 1995 The effect of testosterone on the maturation and developmental capacity of murine oocytes in vitro. Human Reproduction 10 2377-2381. (doi:10.1093/oxfordjournals.humrep.a136302)
9. Anderson E, Lee MT & Lee GY 1992 Cystogenesis of the ovarian antral follicle of the rat: ultrastructural changes and hormonal profile following the administration of dehydroepiandrosterone. Anatomical Record 234 359-382. (doi:10.1002/ar.1092340307)
10. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. 2006 Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism 91 4237-4245. (doi:10.1210/jc.2006-0178)
11. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 91 456-488. (doi:10.1016/j.fertnstert.2008.06.035)
12. Azzolin GC & Saiduddin S 1983 Effect of androgens on the ovarian morphology of the hypophysectomized rat. Proceedings of the Society for Experimental Biology and Medicine 172 70-73. (doi:10.3181/00379727-172-41528)
13. Baculescu N 2013 The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS. Journal of Medicine and Life 6 18-25.
14. Balasch J, Fabregues F, Penarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G & Vanrell JA 2006 Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Human Reproduction 21 1884-1893. (doi:10.1093/humrep/del052)
15. Barad DH & Gleicher N 2005 Increased oocyte production after treatment with dehydroepiandrosterone. Fertility and Sterility 84 756. (doi:10.1016/j.fertnstert.2005.02.049)
16. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL &Rosenthal IM 1994 Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. Journal of Clinical Endocrinology and Metabolism 79 1328-1333. (doi:10.1210/jcem.79.5.7962325)
17. Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo JE, David AL, Hines M & Hardiman PJ 2010 Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. Journal of Obstetrics and Gynaecology 30 444-446. (doi:10.3109/01443615.2010.485254)
18. Becerra-Fernandez A, Perez-Lopez G, Roman MM, Martin-Lazaro JF, Lucio Perez MJ, Asenjo AN, Rodriguez-Molina JM, Berrocal Sertucha MC &Aguilar Vilas MV 2014 Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals. Endocrinología y Nutrición 61 351-358. (doi:10.1016/j.endonu.2014.01.010)
19. Beloosesky R, Gold R, Almog B, Sasson R, Dantes A, Land-Bracha A, Hirsh L, Itskovitz-Eldor J, Lessing JB, Homburg R et al. 2004 Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio. International Journal of Molecular Medicine 14 207-215.
20. Billiar RB, Richardson D, Schwartz R, Posner B & Little B 1987 Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. American Journal of Obstetrics and Gynecology 157 1297-1302. (doi:10.1016/S0002-9378(87)80319-8)
21. Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L & Tarlatzis BC 2012 The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update 18 127-145. (doi:10.1093/humupd/dmr051)
22. Brawer JR, Naftolin F, Martin J & Sonnenschein C 1978 Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology 103 501-512. (doi:10.1210/endo-103-2-501)
23. Broekmans FJ, Soules MR & Fauser BC 2009 Ovarian aging: mechanisms and clinical consequences. Endocrine Reviews 30 465-493. (doi:10.1210/er.2009-0006)
24. Burek M, Duda M, Knapczyk K, Koziorowski M & Slomczynska M 2007 Tissue-specific distribution of the androgen receptor (AR) in the porcine fetus. Acta Histochemica 109 358-365. (doi:10.1016/j.acthis.2007.03.003)
25. Burger HG 2002 Androgen production in women. Fertility and Sterility 77 (Suppl 4) S3-S5. (doi:10.1016/S0015-0282(02)02985-0)
26. Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ & Walters KA 2014 Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155 3146-3159. (doi:10.1210/en.2014-1196)
27. Cardenas H & Pope WF 1994 Administration of testosterone during the follicular phase increased the number of corpora lutea in gilts. Journal of Animal Science 72 2930-2935.
28. Cardenas H, Herrick JR & Pope WF 2002 Increased ovulation rate in gilts treated with dihydrotestosterone. Reproduction 123 527-533. (doi:10.1530/rep.0.1230527)
29. Casson PR, Lindsay MS, Pisarska MD, Carson SA & Buster JE 2000 Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction 15 2129-2132. (doi:10.1093/humrep/15.10.2129)
30. Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D & di Clemente N 2008 Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 93 4456-4461. (doi:10.1210/jc.2008-1231)
31. Chadha S, Pache TD, Huikeshoven JM, Brinkmann AO & van der Kwast TH 1994 Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Human Pathology 25 1198-1204. (doi:10.1016/0046-8177(94)90037-X)
32. Chamberlain NL, Driver ED & Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22 3181-3186. (doi:10.1093/nar/22.15.3181)
33. Chang RJ 2007 The reproductive phenotype in polycystic ovary syndrome. Nature Clinical Practice. Endocrinology & Metabolism 3 688-695. (doi:10.1038/ncpendmet0637)
34. Cheng XB, Jimenez M, Desai R, Middleton LJ, Joseph SR, Ning G, Allan CM, Smith JT, Handelsman DJ & Walters KA 2013 Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice. American Journal of Physiology. Endocrinology and Metabolism 305 E717-E726. (doi:10.1152/ajpendo.00263.2013)
35. Choong CS, Kemppainen JA, Zhou ZX & Wilson EM 1996 Reduced androgen receptor gene expression with first exon CAG repeat expansion. Molecular Endocrinology 10 1527-1535. (doi:10.1210/mend.10.12.8961263)
36. Clarke IJ, Scaramuzzi RJ & Short RV 1976 Sexual differentiation of the brain: endocrine and behavioural responses of androgenized ewes to oestrogen. Journal of Endocrinology 71 175-176. (doi:10.1677/joe.0.0710175)
37. Clarke IJ, Scaramuzzi RJ & Short RV 1977 Ovulation in prenatally androgenized ewes. Journal of Endocrinology 73 385-389. (doi:10.1677/joe.0.0730385)
38. Conway BA, Mahesh VB & Mills TM 1990 Effect of dihydrotestosterone on the growth and function of ovarian follicles in intact immature female rats primed with PMSG. Journal of Reproduction and Fertility 90 267-277. (doi:10.1530/jrf.0.0900267)
39. Conway GS, Dewailly D, Diamanti-Kandarakis E, Escobar MH, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R et al. 2014 The polycystic ovary syndrome: an endocrinological perspective from the European Society of Endocrinology. European Journal of Endocrinology 171 P1-29. (doi:10.1530/EJE-14-0253)
40. Davison SL & Davis SR 2003 Androgens in women. Journal of Steroid Biochemistry and Molecular Biology 85 363-366. (doi:10.1016/S0960-0760(03)00204-8)
41. Davison SL, Bell R, Donath S, Montalto JG & Davis SR 2005 Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology and Metabolism 90 3847-3853. (doi:10.1210/jc.2005-0212)
42. De Gendt K, Swinnen JV, Saunders PT, Schoonjans L, Dewerchin M, Devos A, Tan K, Atanassova N, Claessens F, Lecureuil C et al. 2004 A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. PNAS 101 1327-1332. (doi:10.1073/pnas.0308114100)
43. Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A & Levine JE 2008 Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. American Journal of Physiology. Endocrinology and Metabolism 295 E262-E268. (doi:10.1152/ajpendo.90208.2008)
44. Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J et al. 2004 The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. Journal of Molecular Endocrinology 33 59-72. (doi:10.1677/jme.0.0330059)
45. Dittrich R, Beckmann MW, Oppelt PG, Hoffmann I, Lotz L, Kuwert T & Mueller A 2011 Thyroid hormone receptors and reproduction. Journal of Reproductive Immunology 90 58-66. (doi:10.1016/j.jri.2011.02.009)
46. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N & Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383 531-535. (doi:10.1038/383531a0)
47. Duffy DM, Abdelgadir SE, Stott KR, Resko JA, Stouffer RL & Zelinsk-Wooten MB 1999 Androgen receptor mRNA expression in the rhesus monkey ovary. Endocrine 11 23-30. (doi:10.1385/ENDO:11:1:23)
48. Dumesic DA, Abbott DH, Eisner JR & Goy RW 1997 Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertility and Sterility 67 155-163. (doi:10.1016/S0015-0282(97)81873-0)
49. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R & Abbott DH 2002 Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. Journal of Clinical Endocrinology and Metabolism 87 1111-1119. (doi:10.1210/jcem.87.3.8287)
50. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS & Marshall JC 2000 Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. Journal of Clinical Endocrinology and Metabolism 85 4047-4052. (doi:10.1210/jcem.85.11.6992)
51. Edwards DA 1971 Neonatal administration of androstenedione, testosterone or testosterone propionate: effects on ovulation, sexual receptivity and aggressive behavior in female mice. Physiology & Behavior 6 223-228. (doi:10.1016/0031-9384(71)90030-8)
52. Eisner JR, Barnett MA, Dumesic DA & Abbott DH 2002 Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertility and Sterility 77 167-172. (doi:10.1016/S0015-0282(01)02947-8)
53. Eisner JR, Dumesic DA, Kemnitz JW, Colman RJ & Abbott DH 2003 Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obesity Research 11 279-286. (doi:10.1038/oby.2003.42)
54. Erickson GF, Magoffin DA, Dyer CA & Hofeditz C 1985 The ovarian androgen producing cells: a review of structure/function relationships. Endocrine Reviews 6 371-399. (doi:10.1210/edrv-6-3-371)
55. Fabregues F, Penarrubia J, Creus M, Manau D, Casals G, Carmona F & Balasch J 2009 Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Human Reproduction 24 349-359. (doi:10.1093/humrep/den428)
56. Faiman C, Reyes FI, Dent DW, Fuller GB, Hobson WC & Thliveris JA 1988 Effects of long-term testosterone exposure on ovarian function and morphology in the rhesus monkey. Anatomical Record 222 245-251. (doi:10.1002/ar.1092220305)
57. Familiari G, Toscano V & Motta PM 1985 Morphological studies of polycystic mouse ovaries induced by dehydroepiandrosterone. Cell and Tissue Research 240 519-528. (doi:10.1007/BF00216340)
58. Farookhi R 1985 Effects of aromatizable and nonaromatizable androgen treatments on luteinizing hormone receptors and ovulation induction in immature rats. Biology of Reproduction 33 363-369. (doi:10.1095/biolreprod33.2.363)
59. rdPCOS Consensus Workshop Group. Fertility and Sterility 97 28-38. (doi:10.1016/j.fertnstert.2011.09.024)
60. Fels E & Bosch LR 1971 Effect of prenatal administration of testosterone on ovarian function in rats. American Journal of Obstetrics and Gynecology 111 964-969.
61. Foecking EM, Szabo M, Schwartz NB & Levine JE 2005 Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biology of Reproduction 72 1475-1483. (doi:10.1095/biolreprod.105.039800)
62. Foradori CD, Weiser MJ & Handa RJ 2008 Non-genomic actions of androgens. Frontiers in Neuroendocrinology 29 169-181. (doi:10.1016/j.yfrne.2007.10.005)
63. Forsdike RA, Hardy K, Bull L, Stark J, Webber LJ, Stubbs S, Robinson JE & Franks S 2007 Disordered follicle development in ovaries of prenatally androgenized ewes. Journal of Endocrinology 192 421-428. (doi:10.1677/joe.1.07097)
64. Franks S 1995 Polycystic ovary syndrome. New England Journal of Medicine 333 853-861. (doi:10.1056/NEJM199509283331307)
65. Franks S, Stark J & Hardy K 2008 Follicle dynamics and anovulation in polycystic ovary syndrome. Human Reproduction Update 14 367-378. (doi:10.1093/humupd/dmn015)
66. Futterweit W & Deligdisch L 1986 Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. Journal of Clinical Endocrinology and Metabolism 62 16-21. (doi:10.1210/jcem-62-1-16)
67. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A & Pellicer A 2005 The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertility and Sterility 84 82-87. (doi:10.1016/j.fertnstert.2005.01.117)
68. Ghayee HK & Auchus RJ 2007 Basic concepts and recent developments in human steroid hormone biosynthesis. Reviews in Endocrine & Metabolic Disorders 8 289-300. (doi:10.1007/s11154-007-9052-2)
69. Gill A, Jamnongjit M & Hammes SR 2004 Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Molecular Endocrinology 18 97-104. (doi:10.1210/me.2003-0326)
70. Gilling-Smith C, Willis DS, Beard RW & Franks S 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 79 1158-1165. (doi:10.1210/jcem.79.4.7962289)
71. Gleicher N & Barad DH 2011 Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reproductive Biology and Endocrinology 9 67. (doi:10.1186/1477-7827-9-67)
72. Goldstein JL & Wilson JD 1972 Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization. Journal of Clinical Investigation 51 1647-1658. (doi:10.1172/JCI106966)
73. Goodarzi MO, Dumesic DA, Chazenbalk G & Azziz R 2011 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology 7 219-231. (doi:10.1038/nrendo.2010.217)
74. Hague WM, Adams J, Rodda C, Brook CG, de Bruyn R, Grant DB & Jacobs HS 1990 The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clinical Endocrinology 33 501-510. (doi:10.1111/j.1365-2265.1990.tb03887.x)
75. Hamel M, Vanselow J, Nicola ES & Price CA 2005 Androstenedione increases cytochrome P450 aromatase messenger ribonucleic acid transcripts in nonluteinizing bovine granulosa cells. Molecular Reproduction and Development 70 175-183. (doi:10.1002/mrd.20194)
76. Hampton JH, Manikkam M, Lubahn DB, Smith MF & Garverick HA 2004 Androgen receptor mRNA expression in the bovine ovary. Domestic Animal Endocrinology 27 81-88. (doi:10.1016/j.domaniend.2004.01.005)
77. Harlow CR, Shaw HJ, Hillier SG & Hodges JK 1988 Factors influencing follicle-stimulating hormone-responsive steroidogenesis in marmoset granulosa cells: effects of androgens and the stage of follicular maturity. Endocrinology 122 2780-2787. (doi:10.1210/endo-122-6-2780)
78. Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A et al. 2001 Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biology of Reproduction 64 157-162. (doi:10.1095/biolreprod64.1.157)
79. Hernandez Gifford JA, Hunzicker-Dunn ME & Nilson JH 2009 Conditional deletion of b-catenin mediated by Amhr2cre in mice causes female infertility. Biology of Reproduction 80 1282-1292. (doi:10.1095/biolreprod.108.072280)
80. Hickey T, Chandy A & Norman RJ 2002 The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 161-165. (doi:10.1210/jcem.87.1.8137)
81. Hickey TE, Marrocco DL, Gilchrist RB, Norman RJ & Armstrong DT 2004 Interactions between androgen and growth factors in granulosa cell subtypes of porcine antral follicles. Biology of Reproduction 71 45-52. (doi:10.1095/biolreprod.103.026484)
82. Hickey TE, Marrocco DL, Amato F, Ritter LJ, Norman RJ, Gilchrist RB & Armstrong DT 2005 Androgens augment the mitogenic effects of oocytesecreted factors and growth differentiation factor 9 on porcine granulosa cells. Biology of Reproduction 73 825-832. (doi:10.1095/biolreprod.104.039362)
83. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP & Hart R 2009 The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. Journal of Clinical Endocrinology and Metabolism 94 3714-3720. (doi:10.1210/jc.2009-0544)
84. Hild-Petito S, West NB, Brenner RM & Stouffer RL 1991 Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biology of Reproduction 44 561-568. (doi:10.1095/biolreprod44.3.561)
85. Hillier SG & Ross GT 1979 Effects of exogenous testosterone on ovarian weight, follicular morphologyand intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biology of Reproduction 20 261-268. (doi:10.1095/biolreprod20.2.261)
86. Hillier SG, Tetsuka M & Fraser HM 1997 Location and developmental regulation of androgen receptor in primate ovary. Human Reproduction 12 107-111. (doi:10.1093/humrep/12.1.107)
87. Hogg K, Wood C, McNeilly AS & Duncan WC 2011 The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS ONE 6 e24877. (doi:10.1371/journal.pone.0024877)
88. Hogg K, Young JM, Oliver EM, Souza CJ, McNeilly AS & Duncan WC 2012 Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 153 450-461. (doi:10.1210/en.2011-1607)
89. Holdcraft RW & Braun RE 2004 Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids. Development 131 459-467. (doi:10.1242/dev.00957)
90. Horie K, Takakura K, Fujiwara H, Suginami H, Liao S & Mori T 1992 Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Human Reproduction 7 184-190.
91. Hossain MM, Cao M, Wang Q, Kim JY, Schellander K, Tesfaye D & Tsang BK 2013 Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. Journal of Ovarian Research 6 36. (doi:10.1186/1757-2215-6-36)
92. van Houten EL, Kramer P, McLuskey A, Karels B, Themmen AP & Visser JA 2012 Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology 153 2861-2869. (doi:10.1210/en.2011-1754)
93. Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY & Chang C 2004 Subfertility and defective folliculogenesis in female mice lacking androgen receptor. PNAS 101 11209-11214. (doi:10.1073/pnas.0404372101)
94. Huffman L & Hendricks SE 1981 Prenatally injected testosterone propionate and sexual behavior of female rats. Physiology & Behavior 26 773-778. (doi:10.1016/0031-9384(81)90097-4)
95. Johansson J, Feng Y, Shao R, Lonn M, Billig H & Stener-Victorin E 2010 Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome. American Journal of Physiology. Endocrinology and Metabolism 299 E551-E559. (doi:10.1152/ajpendo.00323.2010)
96. Jorgez CJ, Klysik M, Jamin SP, Behringer RR & Matzuk MM 2004 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Molecular Endocrinology 18 953-967. (doi:10.1210/me.2003-0301)
97. Juengel JL, Heath DA, Quirke LD & McNatty KP 2006 Oestrogen receptor a and b, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep. Reproduction 131 81-92. (doi:10.1530/rep.1.00704)
98. Kamijo T, Mizunuma H, Yamada K & Ibuki Y 1994 In vitro fertilization of androgen sterilized mice. Life Sciences 55 527-531. (doi:10.1016/0024-3205(94)00745-4)
99. Kato S 2002 Androgen receptor structure and function from knock-out mouse. Clinical Pediatric Endocrinology 11 1-7. (doi:10.1297/cpe.11.1)
100. Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE & Welt CK 2014 Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS ONE 9 e93805. (doi:10.1371/journal.pone.0093805)
101. Keisler LW, Vom Saal FS, Keisler DH & Walker SE 1991 Hormonal manipulation of the prenatal environment alters reproductive morphology and increases longevity in autoimmune NZB/W mice. Biology of Reproduction 44 707-716. (doi:10.1095/biolreprod44.4.707)
102. Keller E, Chazenbalk GD, Aguilera P, Madrigal V, Grogan T, Elashoff D, Dumesic DA & Abbott DH 2014 Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys. Endocrinology 155 2696-2703. (doi:10.1210/en.2014-1050)
103. Kendall SK, Samuelson LC, Saunders TL, Wood RI & Camper SA 1995 Targeted disruption of the pituitary glycoprotein hormone α-subunit produces hypogonadal and hypothyroid mice. Genes and Development 9 2007-2019. (doi:10.1101/gad.9.16.2007)
104. Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH & Moon SY 2008 Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertility and Sterility 90 2318-2323. (doi:10.1016/j.fertnstert.2007.10.030)
105. Kim CH, Howles CM & Lee HA 2011 The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertility and Sterility 95 679-683. (doi:10.1016/j.fertnstert.2010.07.1077)
106. Kim JY, Xue K, Cao M, Wang Q, Liu JY, Leader A, Han JY & Tsang BK 2013 Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone. Endocrinology 154 2912-2923. (doi:10.1210/en.2013-1001)
107. King AJ, Olivier NB, Mohankumar PS, Lee JS, Padmanabhan V & Fink GD 2007 Hypertension caused by prenatal testosterone excess in female sheep. American Journal of Physiology. Endocrinology and Metabolism 292 E1837-E1841. (doi:10.1152/ajpendo.00668.2006)
108. Kuhn R & Torres RM 2002 Cre/loxP recombination system and gene targeting. Methods in Molecular Biology 180 175-204.
109. Kumari GL, Datta JK & Roy S 1978 Evidence for a role of androgens in the growth and maturation of ovarian follicles in rats. Hormone Research 9 112-120. (doi:10.1159/000178903)
110. Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y & Kang J 2014 High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biology of Reproduction 91 127. (doi:10.1095/biolreprod.114.120063)
111. Laisk T, Haller-Kikkatalo K, Laanpere M, Jakovlev U, Peters M, Karro H & Salumets A 2010 Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels. Acta Obstetricia et Gynecologica Scandinavica 89 1557-1563. (doi:10.3109/00016349.2010.526182)
112. Lee MT, Anderson E & Lee GY 1991 Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anatomical Record 231 185-192. (doi:10.1002/ar.1092310206)
113. Lenie S & Smitz J 2009 Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biology of Reproduction 80 685-695. (doi:10.1095/biolreprod.107.067280)
114. Li M, Ai JS, Xu BZ, Xiong B, Yin S, Lin SL, Hou Y, Chen DY, Schatten H &Sun QY 2008 Testosterone potentially triggers meiotic resumption by activation of intra-oocyte SRC and MAPK in porcine oocytes. Biology of Reproduction 79 897-905. (doi:10.1095/biolreprod.108.069245)
115. Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M, Kaldrymides P, Panidis D & Diamanti-Kandarakis E 2014 Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine 47 631-638. (doi:10.1007/s12020-014-0200-7)
116. Longcope C 1986 Adrenal and gonadal androgen secretion in normal females. Journal of Clinical Endocrinology and Metabolism 15 213-228. (doi:10.1016/S0300-595X(86)80021-4)
117. Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsboll S & Andersen AN 2008 Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Human Reproduction 23 1820-1829. (doi:10.1093/humrep/den131)
118. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS & Wilson EM 1988 Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240 327-330. (doi:10.1126/science.3353727)
119. Lucis OJ, Hobkirk R, Hollenberg CH, MacDonald SA & Blahey P 1966 Polycystic ovaries associated with congenital adrenal hyperplasia. Canadian Medical Association Journal 94 1-7.
120. Lyon MF & Glenister PH 1974 Evidence from Tfm-O that androgen is inessential for reproduction in female mice. Nature 247 366-367. (doi:10.1038/247366a0)
121. Lyon MF & Glenister PH 1980 Reduced reproductive performance in androgen-resistant Tfm/Tfm female mice. Proceedings of the Royal Society of London. Series B, Biological Sciences 208 1-12. (doi:10.1098/rspb.1980.0040)
122. Maliqueo M, Lara HE, Sanchez F, Echiburu B, Crisosto N & Sir-Petermann T 2013 Placental steroidogenesis in pregnant women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 166 151-155. (doi:10.1016/j.ejogrb.2012.10.015)
123. Manikkam M, Steckler TL, Welch KB, Inskeep EK & Padmanabhan V 2006 Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology 147 1997-2007. (doi:10.1210/en.2005-1338)
124. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M & Stener-Victorin E 2007 A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148 3781-3791. (doi:10.1210/en.2007-0168)
125. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP &Hugues JN 2006 Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique - a prospective, randomized, double-blind study. Human Reproduction 21 1204-1211. (doi:10.1093/humrep/dei481)
126. McDonald PG & Doughty C 1972 Comparison of the effect of neonatal administration of testosterone and dihydrotestosterone in the female rat. Journal of Reproduction and Fertility 30 55-62. (doi:10.1530/jrf.0.0300055)
127. McGee WK, Bishop CV, Bahar A, Pohl CR, Chang RJ, Marshall JC, Pau FK, Stouffer RL & Cameron JL 2012 Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Human Reproduction 27 531-540. (doi:10.1093/humrep/der393)
128. Meldrum DR, Chang RJ, Giudice LC, Balasch J & Barbieri RL 2013 Role of decreased androgens in the ovarian response to stimulation in older women. Fertility and Sterility 99 5-11. (doi:10.1016/j.fertnstert.2012.10.011)
129. Mifsud A, Ramirez S & Yong EL 2000 Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 85 3484-3488. (doi:10.1210/jcem.85.9.6832)
130. Miller WL & Auchus RJ 2011 The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocrine Reviews 32 81-151. (doi:10.1210/er.2010-0013)
131. Moore AM, Prescott M & Campbell RE 2013 Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology 154 796-806. (doi:10.1210/en.2012-1954)
132. Mori T, Suzuki A, Nishimura T & Kambegawa A 1977 Evidence for androgen participation in induced ovulation in immature rats. Endocrinology 101 623-626. (doi:10.1210/endo-101-2-623)
133. Murray AA, Gosden RG, Allison V & Spears N 1998 Effect of androgens on the development of mouse follicles growing in vitro. Journal of Reproduction and Fertility 113 27-33. (doi:10.1530/jrf.0.1130027)
134. Narkwichean A, Maalouf W, Campbell BK & Jayaprakasan K 2013 Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reproductive Biology and Endocrinology 11 44. (doi:10.1186/1477-7827-11-44)
135. Narkwichean A, Jayaprakasan K, Maalouf WE, Hernandez-Medrano JH, Pincott-Allen C & Campbell BK 2014 Effects of dehydroepiandrosterone on in vivo ovine follicular development. Human Reproduction 29 146-154. (doi:10.1093/humrep/det408)
136. Nelson VL, Legro RS, Strauss JF III & McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 13 946-957. (doi:10.1210/mend.13.6.0311)
137. Nielsen ME, Rasmussen IA, Kristensen SG, Christensen ST, Mollgard K, Wreford AE, Byskov AG & Yding AC 2011 In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Molecular Human Reproduction 17 63-70. (doi:10.1093/molehr/gaq073)
138. Notini AJ, Davey RA, McManus JF, Bate KL & Zajac JD 2005 Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model. Journal of Molecular Endocrinology 35 547-555. (doi:10.1677/jme.1.01884)
139. Ohno S, Christian L & Attardi B 1973 Role of testosterone in normal female function. Nature: New Biology 243 119-120. (doi:10.1038/243119a0)
140. Ortega HH, Salvetti NR & Padmanabhan V 2009 Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction 137 865-877. (doi:10.1530/REP-08-0491)
141. Ota H, Fukushima M & Maki M 1983 Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate. Tohoku Journal of Experimental Medicine 140 121-131. (doi:10.1620/tjem.140.121)
142. Ozmen B, Sonmezer M, Atabekoglu CS & Olmus H 2009 Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols. Reproductive Biomedicine Online 19 478-485. (doi:10.1016/j.rbmo.2009.05.007)
143. Pache TD & Fauser BC 1993 Polycystic ovaries in female-to-male transsexuals. Clinical Endocrinology 39 702-703.
144. Padmanabhan V & Veiga-Lopez A 2013 Sheep models of polycystic ovary syndrome phenotype. Molecular and Cellular Endocrinology 373 8-20. (doi:10.1016/j.mce.2012.10.005)
145. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE & Herkimer C 2010 Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 151 595-605. (doi:10.1210/en.2009-1015)
146. Palomba S, Falbo A, Chiossi G, Muscogiuri G, Fornaciari E, Orio F, Tolino A, Colao A, La Sala GB & Zullo F 2014 Lipid profile in nonobese pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. Steroids 88C 36-43. (doi:10.1016/j.steroids.2014.06.005)
147. Paradisi R, Fabbri R, Battaglia C & Venturoli S 2013 Ovulatory effects of flutamide in the polycystic ovary syndrome. Gynecological Endocrinology 29 391-395. (doi:10.3109/09513590.2012.754876)
148. Pasquali R, Stener-Victorin E, Yildiz BO, Duleba AJ, Hoeger K, Mason H, Homburg R, Hickey T, Franks S, Tapanainen J et al. 2010 PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clinical Endocrinology 74 424-433. (doi:10.1111/j.1365-2265.2010.03956.x)
149. Persani L, Rossetti R & Cacciatore C 2010 Genes involved in human premature ovarian failure. Journal of Molecular Endocrinology 45 257-279. (doi:10.1677/JME-10-0070)
150. Pinilla L, Trimino E, Garnelo P, Bellido C, Aguilar R, Gaytan F & Aguilar E 1993 Changes in pituitary secretion during the early postnatal period and anovulatory syndrome induced by neonatal oestrogen or androgen in rats. Journal of Reproduction and Fertility 97 13-20. (doi:10.1530/jrf.0.0970013)
151. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM & French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 16 271-321. (doi:10.1210/edrv-16-3-271)
152. Raja-Khan N, Urbanek M, Rodgers RJ & Legro RS 2014 The role of TGF-β in polycystic ovary syndrome. Reproductive Sciences 21 20-31. (doi:10.1177/1933719113485294)
153. Ramezani TF, Noroozzadeh M, Zahediasl S, Piryaei A, Hashemi S & Azizi F 2014 The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats. International Journal of Endocrinology and Metabolism 12 e16502. (doi:10.5812/ijem.16502)
154. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Duran C, Vidal M, Foster DL & Sir-Petermann T 2005 Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. American Journal of Physiology. Endocrinology and Metabolism 289 E801-E806. (doi:10.1152/ajpendo.00107.2005)
155. Rice S, Ojha K, Whitehead S & Mason H 2007 Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Mullerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 92 1034-1040. (doi:10.1210/jc.2006-1697)
156. Richardson SJ 1993 The biological basis of the menopause. Baillière's Clinical Endocrinology and Metabolism 7 1-16.
157. Rittmaster RS 1999 Antiandrogen treatment of polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America 28 409-421. (doi:10.1016/S0889-8529(05)70077-3)
158. Roland AV, Nunemaker CS, Keller SR & Moenter SM 2010 Prenatal androgen exposure programs metabolic dysfunction in female mice. Journal of Endocrinology 207 213-223. (doi:10.1677/JOE-10-0217)
159. Romero S & Smitz J 2010 Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androgens influences the steroid balance and reduces oocyte meiotic capacity. Endocrine 38 243-253. (doi:10.1007/s12020-010-9380-y)
160. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 41-47. (doi:10.1093/humrep/deh098)
161. Salvetti NR, Alfaro NS, Velazquez MM, Amweg AN, Matiller V, Diaz PU &Ortega HH 2012 Alteration in localization of steroid hormone receptors and coregulatory proteins in follicles from cows with induced ovarian follicular cysts. Reproduction 144 723-735. (doi:10.1530/REP-12-0188)
162. Sander V, Luchetti CG, Solano ME, Elia E, Di GG, Gonzalez C & Motta AB 2006 Role of the N,N′-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction 131 591-602. (doi:10.1530/rep.1.00941)
163. Sarma HN, Manikkam M, Herkimer C, Dell'Orco J, Welch KB, Foster DL &Padmanabhan V 2005 Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 146 4281-4291. (doi:10.1210/en.2005-0322)
164. Savabieasfahani M, Lee JS, Herkimer C, Sharma TP, Foster DL &Padmanabhan V 2005 Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period. Biology of Reproduction 72 221-229. (doi:10.1095/biolreprod.104.031070)
165. Schuring AN, Welp A, Gromoll J, Zitzmann M, Sonntag B, Nieschlag E, Greb RR & Kiesel L 2012 Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS). Experimental and Clinical Endocrinology & Diabetes 120 73-79. (doi:10.1055/s-0031-1291343)
166. Sen A & Hammes SR 2010 Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Molecular Endocrinology 24 1393-1403. (doi:10.1210/me.2010-0006)
167. Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R & Hammes SR 2012 Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. Journal of Clinical Investigation 122 2469-2481. (doi:10.1172/JCI62044)
168. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N & Hammes SR 2014 Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. PNAS 111 3008-3013. (doi:10.1073/pnas.1318978111)
169. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ & deVere White RW 2007 An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. PNAS 104 19983-19988. (doi:10.1073/pnas.0706641104)
170. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, Sakari M, Takada I, Nakamura T, Metzger D et al. 2006 Premature ovarian failure in androgen receptor-deficient mice. PNAS 103 224-229. (doi:10.1073/pnas.0506736102)
171. Simanainen U, Brogley M, Gao YR, Jimenez M, Harwood DT, Handelsman DJ & Robins DM 2011 Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Molecular and Cellular Endocrinology 342 81-86. (doi:10.1016/j.mce.2011.05.011)
172. Sipe CS, Thomas MR, Stegmann BJ & Van Voorhis BJ 2010 Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. Human Reproduction 25 690-696. (doi:10.1093/humrep/dep442)
173. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F &Recabarren SE 2002 Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Human Reproduction 17 2573-2579. (doi:10.1093/humrep/17.10.2573)
174. Skrgatic L, Baldani DP, Cerne JZ, Ferk P & Gersak K 2012 CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels. Journal of Steroid Biochemistry and Molecular Biology 128 107-112. (doi:10.1016/j.jsbmb.2011.11.006)
175. Slob AK, den Hamer R, Woutersen PJ & van der Werff ten Bosch JJ 1983 Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinologica 103 420-427. (doi:10.1530/acta.0.1030420)
176. Slomczynska M & Tabarowski Z 2001 Localization of androgen receptor and cytochrome P450 aromatase in the follicle and corpus luteum of the porcine ovary. Animal Reproduction Science 65 127-134. (doi:10.1016/S0378-4320(00)00225-6)
177. Slomczynska M, Duda M & Sl zak K 2001 The expression of androgen receptor, cytochrome P450 aromatase and FSH receptor mRNA in the porcine ovary. Folia Histochemica et Cytobiologica 39 9-13.
178. Smith P, Steckler TL, Veiga-Lopez A & Padmanabhan V 2009 Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biology of Reproduction 80 726-736. (doi:10.1095/biolreprod.108.072801)
179. Sorensen AE, Wissing ML, Salo S, Englund AL & Dalgaard LT 2014 MicroRNAs related to polycystic ovary syndrome (PCOS). Genes 5 684-708. (doi:10.3390/genes5030684)
180. Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG & Gooren LJ 1989 The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. Journal of Clinical Endocrinology and Metabolism 69 151-157. (doi:10.1210/jcem-69-1-151)
181. Steckler T, Manikkam M, Inskeep EK & Padmanabhan V 2007 Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 148 3532-3540. (doi:10.1210/en.2007-0339)
182. Steckler TL, Herkimer C, Dumesic DA & Padmanabhan V 2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication for polycystic ovary syndrome. Endocrinology 150 1456-1465. (doi:10.1210/en.2008-1256)
183. Stener-Victorin E, Ploj K, Larsson BM & Holmang A 2005 Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reproductive Biology and Endocrinology 3 44. (doi:10.1186/1477-7827-3-44)
184. Stubbs SA, Webber LJ, Stark J, Rice S, Margara R, Lavery S, Trew GH, Hardy K & Franks S 2013 Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries. Journal of Clinical Endocrinology and Metabolism 98 3298-3305. (doi:10.1210/jc.2013-1378)
185. Sugawa F, Wada Y, Maruyama T, Uchida H, Ishizuka B & Ogata T 2008 Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns. Fertility and Sterility 91 649-652. (doi:10.1016/j.fertnstert.2007.11.085)
186. Sullivan SD & Moenter SM 2004 Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. PNAS 101 7129-7134. (doi:10.1073/pnas.0308058101)
187. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A & Nagura H 1994 Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Human Reproduction 9 1589-1595.
188. Swanson HE & Werff ten Bosch JJ 1964 The "early-androgen" syndrome; differences in response to pre-natal and post-natal administration of various doses of testosterone propionate in female and male rats. Acta Endocrinologica 47 37-50.
189. Swanson HE & Werff ten Bosch JJ 1965 The "early-androgen" syndrome; effects of pre-natal testosterone propionate. Acta Endocrinologica 50 379-390.
190. Szoltys M & Slomczynska M 2000 Changes in distribution of androgen receptor during maturation of rat ovarian follicles. Experimental and Clinical Endocrinology & Diabetes 108 228-234. (doi:10.1055/s-2000-7747)
191. Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K & Kitao M 1994 Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Human Reproduction 9 1231-1236.
192. Tandulwadkar SR, Lodha PA & Mangeshikar NT 2014 Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome. Journal of Human Reproductive Sciences 7 13-18. (doi:10.4103/0974-1208.130802)
193. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S & Erickson GF 2002 Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 1337-1344. (doi:10.1210/jcem.87.3.8316)
194. Treloar OL, Wolf RC & Meyer RK 1972 Failure of a single neonatal dose of testosterone to alter ovarian function in the Rhesus monkey. Endocrinology 90 281-284. (doi:10.1210/endo-90-1-281)
195. Tyndall V, Broyde M, Sharpe R, Welsh M, Drake AJ & McNeilly AS 2012 Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction 143 21-33. (doi:10.1530/REP-11-0239)
196. Veiga-Lopez A, Astapova OI, Aizenberg EF, Lee JS & Padmanabhan V 2009 Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biology of Reproduction 80 718-725. (doi:10.1095/biolreprod.108.074781)
197. Veiga-Lopez A, Moeller J, Patel D, Ye W, Pease A, Kinns J & Padmanabhan V 2013 Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology 154 1731-1742. (doi:10.1210/en.2012-2145)
198. Vendola KA, Zhou J, Adesanya OO, Weil SJ & Bondy CA 1998 Androgens stimulate early stages of follicular growth in the primate ovary. Journal of Clinical Investigation 101 2622-2629. (doi:10.1172/JCI2081)
199. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M & Bondy CA 1999a Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biology of Reproduction 61 353-357. (doi:10.1095/biolreprod61.2.353)
200. Vendola K, Zhou J, Wang J & Bondy CA 1999b Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Human Reproduction 14 2328-2332. (doi:10.1093/humrep/14.9.2328)
201. Walters KA, Binnie JP, Campbell BK, Armstrong DG & Telfer EE 2006 The effects of IGF-I on bovine follicle development and IGFBP-2 expression are dose and stage dependent. Reproduction 131 515-523. (doi:10.1530/rep.1.00682)
202. Walters KA, Allan CM, Jimenez M, Lim PR, Davey RA, Zajac JD, Illingworth P & Handelsman DJ 2007 Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology 148 3674-3684. (doi:10.1210/en.2007-0248)
203. Walters KA, Allan CM & Handelsman DJ 2008 Androgen actions and the ovary. Biology of Reproduction 78 380-389. (doi:10.1095/biolreprod.107.064089)
204. Walters KA, McTavish KJ, Seneviratne MG, Jimenez M, McMahon AC, Allan CM, Salamonsen LA & Handelsman DJ 2009 Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function. Endocrinology 150 3274-3282. (doi:10.1210/en.2008-1750)
205. Walters KA, Simanainen U & Handelsman DJ 2010 Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Human Reproduction Update 16 543-558. (doi:10.1093/humupd/dmq003)
206. Walters KA, Middleton LJ, Joseph SR, Hazra R, Jimenez M, Simanainen U, Allan CM & Handelsman DJ 2012a Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility. Biology of Reproduction 87 151. (doi:10.1095/biolreprod.112.102012)
207. Walters KA, Allan CM & Handelsman DJ 2012b Rodent models for human polycystic ovary syndrome. Biology of Reproduction 86 149. 1-149,12. (doi:10.1095/biolreprod.111.097808)
208. Wang H, Andoh K, Hagiwara H, Xiaowei L, Kikuchi N, Abe Y, Yamada K, Fatima R & Mizunuma H 2001 Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice. Endocrinology 142 4930-4936. (doi:10.1210/endo.142.11.8482)
209. Wang Q, Kim JY, Xue K, Liu JY, Leader A & Tsang BK 2012 Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology 153 5600-5611. (doi:10.1210/en.2012-1424)
210. Ward RC, Costoff A & Mahesh VB 1978 The induction of polycystic ovaries in mature cycling rats by the administration of dehydroepiandrosterone (DHA). Biology of Reproduction 18 614-623. (doi:10.1095/biolreprod18.4.614)
211. Ware VC 1982 The role of androgens in follicular development in the ovary. I. A quantitative analysis of oocyte ovulation. Journal of Experimental Zoology 222 155-167. (doi:10.1002/jez.1402220207)
212. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J & Bondy CA 1998 Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. Journal of Clinical Endocrinology and Metabolism 83 2479-2485. (doi:10.1210/jcem.83.7.4917)
213. Weil S, Vendola K, Zhou J & Bondy CA 1999 Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. Journal of Clinical Endocrinology and Metabolism 84 2951-2956. (doi:10.1210/jcem.84.8.5929)
214. Weisz J & Lloyd CW 1965 Estrogen and androgen production in vitro from 7-3-H-progesterone by normal and polycystic rat ovaries. Endocrinology 77 735-744. (doi:10.1210/endo-77-4-735)
215. West C, Foster DL, Evans NP, Robinson J & Padmanabhan V 2001 Intrafollicular activin availability is altered in prenatally-androgenized lambs. Molecular and Cellular Endocrinology 185 51-59. (doi:10.1016/S0303-7207(01)00632-3)
216. Wilson CM & McPhaul MJ 1996 A and B forms of the androgen receptor are expressed in a variety of human tissues. Molecular and Cellular Endocrinology 120 51-57. (doi:10.1016/0303-7207(96)03819-1)
217. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A & Shulman A 2010 Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Human Reproduction 25 2496-2500. (doi:10.1093/humrep/deq220)
218. Wu XY, Li ZL, Wu CY, Liu YM, Lin H, Wang SH & Xiao WF 2010a Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats. Endocrine Journal 57 201-209. (doi:10.1507/endocrj.K09E-205)
219. Wu CH, Yang JG, Yang JJ, Lin YM, Tsai HD, Lin CY & Kuo PL 2010b Androgen excess down-regulates connexin43 in a human granulosa cell line. Fertility and Sterility 94 2938-2941. (doi:10.1016/j.fertnstert.2010.06.077)
220. Wu YG, Bennett J, Talla D & Stocco C 2011 Testosterone, not 5adihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells. Molecular Endocrinology 25 656-668. (doi:10.1210/me.2010-0367)
221. Wu S, Chen Y, Fajobi T, DiVall SA, Chang C, Yeh S & Wolfe A 2014 Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice. Molecular Endocrinology 28 1670-1681. (doi:10.1210/me.2014-1154)
222. Xita N & Tsatsoulis A 2006 Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. Journal of Clinical Endocrinology and Metabolism 91 1660-1666. (doi:10.1210/jc.2005-2757)
223. Xu N, Kwon S, Abbott DH, Geller DH, Dumesic DA, Azziz R, Guo X &Goodarzi MO 2011 Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS ONE 6 e27286. (doi:10.1371/journal.pone.0027286)
224. Yan X, Dai X, Wang J, Zhao N, Cui Y & Liu J 2013 Prenatal androgen excess programs metabolic derangements in pubertal female rats. Journal of Endocrinology 217 119-129. (doi:10.1530/JOE-12-0577)
225. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R, Racusen LC & Reckelhoff JF 2011 Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gender Medicine 8 103-115. (doi:10.1016/j.genm.2010.11.013)
226. Yang MY & Fortune JE 2006 Testosterone stimulates the primary to secondary follicle transition in bovine follicles in vitro. Biology of Reproduction 75 924-932. (doi:10.1095/biolreprod.106.051813)
227. Yang JL, Zhang CP, Li L, Huang L, Ji SY, Lu CL, Fan CH, Cai H, Ren Y, Hu ZY et al. 2010 Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology 151 774-782. (doi:10.1210/en.2009-0751)
228. Yazawa T, Kawabe S, Kanno M, Mizutani T, Imamichi Y, Ju Y, Matsumura T, Yamazaki Y, Usami Y, Kuribayashi M et al. 2013 Androgen/androgen receptor pathway regulates expression of the genes for cyclooxygenase-2 and amphiregulin in periovulatory granulosa cells. Molecular and Cellular Endocrinology 369 42-51. (doi:10.1016/j.mce.2013.02.004)
229. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X et al. 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. PNAS 99 13498-13503. (doi:10.1073/pnas.212474399)
230. Yeung TW, Chai J, Li RH, Lee VC, Ho PC & Ng EH 2014 A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders. Fertility and Sterility 102 108-115. (doi:10.1016/j.fertnstert.2014.03.044)
231. Zawadski JK & Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, pp 377-384. Eds A Dunaif, JR Givens, FP Haseltine& GR Merriam. Boston: Blackwell Scientific Publications.
232. Zumoff B, Strain GW, Miller LK & Rosner W 1995 Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. Journal of Clinical Endocrinology and Metabolism 80 1429-1430.